Émilie Chalayer

629 total citations
32 papers, 245 citations indexed

About

Émilie Chalayer is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Émilie Chalayer has authored 32 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Genetics and 9 papers in Internal Medicine. Recurrent topics in Émilie Chalayer's work include Venous Thromboembolism Diagnosis and Management (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Émilie Chalayer is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Émilie Chalayer collaborates with scholars based in France, United States and Switzerland. Émilie Chalayer's co-authors include P. Cathébras, Martine Ffrench, Bernard Tardy, Martin Killian, Stéphane Paul, Denis Guyotat, Lionel Karlin, Michel Pavic, P. Sève and Emmanuel Bachy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Émilie Chalayer

25 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Émilie Chalayer France 11 110 61 56 40 39 32 245
M. Le Besnerais France 11 54 0.5× 89 1.5× 35 0.6× 34 0.8× 48 1.2× 23 290
Paul Billoir France 9 100 0.9× 70 1.1× 44 0.8× 67 1.7× 18 0.5× 35 286
Simona Raso Italy 10 114 1.0× 24 0.4× 84 1.5× 54 1.4× 14 0.4× 37 251
Eva Leinøe Denmark 10 232 2.1× 17 0.3× 81 1.4× 29 0.7× 36 0.9× 31 338
Eapen K. Jacob United States 11 144 1.3× 24 0.4× 18 0.3× 13 0.3× 50 1.3× 37 328
Andrea Duminuco Italy 11 128 1.2× 26 0.4× 142 2.5× 14 0.3× 32 0.8× 60 344
Judith S. Hecker Germany 10 77 0.7× 30 0.5× 52 0.9× 91 2.3× 26 0.7× 23 339
Alessandra Borchiellini Italy 9 261 2.4× 35 0.6× 74 1.3× 14 0.3× 69 1.8× 31 328
Cengiz Canpolat Türkiye 10 40 0.4× 36 0.6× 19 0.3× 7 0.2× 40 1.0× 29 223
Fahrettin Covut United States 9 85 0.8× 8 0.1× 24 0.4× 38 0.9× 27 0.7× 39 312

Countries citing papers authored by Émilie Chalayer

Since Specialization
Citations

This map shows the geographic impact of Émilie Chalayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Émilie Chalayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Émilie Chalayer more than expected).

Fields of papers citing papers by Émilie Chalayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Émilie Chalayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Émilie Chalayer. The network helps show where Émilie Chalayer may publish in the future.

Co-authorship network of co-authors of Émilie Chalayer

This figure shows the co-authorship network connecting the top 25 collaborators of Émilie Chalayer. A scholar is included among the top collaborators of Émilie Chalayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Émilie Chalayer. Émilie Chalayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chalayer, Émilie, et al.. (2025). Prediction of thrombotic events in patients with autoimmune hemolytic anemia: a multicenter retrospective observational study. Journal of Thrombosis and Thrombolysis. 58(7). 945–954.
2.
Péoc’h, Michel, et al.. (2025). Concomitant Diagnosis and Therapeutic Response of Large-vessel Vasculitis and Hodgkin Lymphoma on 18F-FDG PET/CT. Clinical Nuclear Medicine. 50(12). 1233–1235.
3.
Papadopoulou, Vasiliki, et al.. (2025). Management of thrombocytopenia and anticoagulant therapy in patients with hematological malignancy on chemotherapy: a binational prospective study (TAT study). Journal of Thrombosis and Thrombolysis. 58(5). 646–656. 1 indexed citations
4.
Gaballa, Mahmoud, Nobuhiro Tsukada, Kazuhito Suzuki, et al.. (2024). Real-World Experience with Isatuximab in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Iona-MM Second Interim Analysis. Blood. 144(Supplement 1). 2411.5–2411.5. 1 indexed citations
5.
Frenzel, Laurent, Olivier Decaux, Margaret Macro, et al.. (2023). Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group. Thrombosis Research. 233. 153–164. 13 indexed citations
6.
7.
Garraud, Olivier, Hind Hamzeh‐Cognasse, Émilie Chalayer, et al.. (2022). Platelet transfusion in adults: An update. Transfusion Clinique et Biologique. 30(1). 147–165. 15 indexed citations
8.
Chalayer, Émilie, Alexis Talbot, Laurent Frenzel, et al.. (2022). Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort. Journal of Thrombosis and Haemostasis. 20(8). 1859–1867. 10 indexed citations
9.
Killian, Martin, Sébastien Viel, Émilie Chalayer, et al.. (2021). JAK1/2 Inhibition in Severe TAFRO Syndrome: A Case Report. Annals of Internal Medicine. 174(5). 719–721. 10 indexed citations
10.
Groh, Matthieu, Laura Venditti, Émilie Chalayer, et al.. (2021). FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction. Stroke. 52(10). e605–e609. 5 indexed citations
11.
Chalayer, Émilie, et al.. (2021). Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmunity Reviews. 21(3). 103016–103016. 29 indexed citations
12.
Killian, Martin, et al.. (2021). Management of bone marrow biopsy related bleeding risks: a retrospective observational study. Journal of Thrombosis and Thrombolysis. 54(1). 109–114.
13.
Genthon, Alexis, Martin Killian, Philippe Mertz, et al.. (2020). Les myélofibroses. La Revue de Médecine Interne. 42(2). 101–109. 4 indexed citations
14.
Chalayer, Émilie, et al.. (2019). <p>Graduated compression stockings in prevention of venous thromboembolism among acutely ill medical patients aged over 75 years: a French national survey</p>. Clinical Interventions in Aging. Volume 14. 1153–1157. 1 indexed citations
15.
Tavernier, Emmanuelle, Émilie Chalayer, Jérôme Cornillon, et al.. (2018). Fulminant hepatitis due to very severe sinusoidal obstruction syndrome (SOS/VOD) after autologous peripheral stem cell transplantation: a case report. BMC Research Notes. 11(1). 436–436. 4 indexed citations
16.
Chalayer, Émilie, N. Costedoat‐Chalumeau, Odile Beyne‐Rauzy, et al.. (2017). Bone marrow involvement in systemic lupus erythematosus. QJM. 110(11). 701–711. 22 indexed citations
17.
Chalayer, Émilie, Aurélie Bourmaud, Fabien Tinquaut, Franck Chauvin, & Bernard Tardy. (2016). Cost-effectiveness analysis of low-molecular-weight heparin versus aspirin thromboprophylaxis in patients newly diagnosed with multiple myeloma. Thrombosis Research. 145. 119–125. 6 indexed citations
18.
Chalayer, Émilie, Emmanuel Bachy, Pauline Occelli, et al.. (2015). Sarcoidosis and lymphoma: a comparative study. QJM. 108(11). 871–878. 24 indexed citations
19.
Chalayer, Émilie, Martine Ffrench, & P. Cathébras. (2014). Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review. Rheumatology International. 35(6). 1073–1082. 10 indexed citations
20.
Chalayer, Émilie, Martine Ffrench, & P. Cathébras. (2014). Bone marrow fibrosis as a feature of systemic lupus erythematosus: a case report and literature review. SpringerPlus. 3(1). 349–349. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Le Besnerais Breakdown of academic impact, for papers by Paul Billoir Breakdown of academic impact, for papers by Simona Raso Breakdown of academic impact, for papers by Eva Leinøe Breakdown of academic impact, for papers by Eapen K. Jacob Breakdown of academic impact, for papers by Andrea Duminuco Breakdown of academic impact, for papers by Judith S. Hecker Breakdown of academic impact, for papers by Alessandra Borchiellini Breakdown of academic impact, for papers by Cengiz Canpolat Breakdown of academic impact, for papers by Fahrettin Covut
Rankless by CCL
2026